Skip to main content
Clinical Trials/ACTRN12620000564954
ACTRN12620000564954
Recruiting
未知

Evaluation of Outcomes Following Tricuspid Valve Cylinder Reconstruction with CardioCel® in Isolated Severe Tricuspid Regurgitation

The Alfred0 sites10 target enrollmentMay 14, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Tricuspid Regurgitation
Sponsor
The Alfred
Enrollment
10
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 14, 2020
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
The Alfred

Eligibility Criteria

Inclusion Criteria

  • Is ambulatory, able and willing to comply with the study protocol and has provided written informed consent
  • Aged 18\-85 years, inclusive
  • Symptomatic with TR grade greater than or equal to 3\+
  • Preserved right ventricular function
  • In the opinion of the investigator and heart surgery team, the patient is not an appropriate candidate for tricuspid annuloplasty

Exclusion Criteria

  • In the opinion of the investigator and heart surgery team, the patient is an appropriate candidate for tricuspid annuloplasty
  • Haemodynamic instability (systolic pressure \< 90mmHg without after load reduction or cardiogenic shock or the need for inotropic support or intra\-aortic balloon pump)
  • Model for End\-stage Liver Disease (MELD score) \> 15
  • Suspected inability to adhere to adhere to follow\-up
  • Patients in whom TTE, TOE, (or MRI) is contraindicated
  • A known need for any other cardiac surgery
  • Inability to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials